Diversity and short-chain fatty acid signatures of gut microbiome as prognostic marker for diabetes onset in the LEW.1AR1-iddm rat model of autoimmune diabetes

被引：0
|
作者：
Schoeppe, T. [1 ]
Kreikemeyer, B. [1 ]
Herlemann, D. [2 ]
Sachs, J. -H. [1 ]
Baltrusch, S. [1 ]
Tiedge, M. [1 ]
机构：
[1] Rostock Univ, Med Ctr, Rostock, Germany
[2] Estonian Univ Life Sci, Tartu, Estonia
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
350
引用
收藏
页码：S174 / S175
页数：2
相关论文
共 50 条
  • [31] The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus
    S. Lenzen
    M. Tiedge
    M. Elsner
    S. Lortz
    H. Weiss
    A. Jörns
    G. Klöppel
    D. Wedekind
    C. -M. Prokop
    H. J. Hedrich
    Diabetologia, 2001, 44 : 1189 - 1196
  • [32] Variation of peripheral CD3+ T-lymphocyte content in the diabetic LEW.1AR1-iddm rat is associated with a diabetes susceptibility region on RNO1
    Weiss, H
    Tiedge, M
    Lenzen, S
    Hedrich, HJ
    Wedekind, D
    DIABETOLOGIA, 2004, 47 : A131 - A131
  • [33] Asymmetric dimethylation and citrullination in the LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, and effects of anti-TCR/anti-TNF-α antibody-based therapy
    Alexander Bollenbach
    Dimitrios Tsikas
    Sigurd Lenzen
    Anne Jörns
    Amino Acids, 2020, 52 : 103 - 110
  • [34] Asymmetric dimethylation and citrullination in the LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, and effects of anti-TCR/anti-TNF-α antibody-based therapy
    Bollenbach, Alexander
    Tsikas, Dimitrios
    Lenzen, Sigurd
    Joerns, Anne
    AMINO ACIDS, 2020, 52 (01) : 103 - 110
  • [35] Immunomodulatory therapies with anti-IL-6 and anti-IL-17 combined with anti-TCR to regain normoglycaemia in the LEW.1AR1-iddm rat as a model for human type 1 diabetes
    Joerns, A.
    Teraoku, H.
    Yoshimoto, T.
    Wedekind, D.
    Lenzen, S.
    DIABETOLOGIA, 2018, 61 : S212 - S212
  • [36] Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes
    Harbison, Jessica E.
    Thomson, Rebecca L.
    Wentworth, John M.
    Louise, Jennie
    Roth-Schulze, Alexandra
    Battersby, Rachel J.
    Ngui, Katrina M.
    Penno, Megan A. S.
    Colman, Peter G.
    Craig, Maria E.
    Barry, Simon C.
    Tran, Cuong D.
    Makrides, Maria
    Harrison, Leonard C.
    Couper, Jennifer J.
    PEDIATRIC DIABETES, 2021, 22 (03) : 425 - 433
  • [37] Cytokine pattern and iNOS expression in different infiltration stages of islets in the LEW.1AR1/Ztm-iddm rat, a new model of Type 1 diabetes
    Jörns, A
    Tiedge, M
    Hedrich, HJ
    Lenzen, S
    DIABETOLOGIA, 2004, 47 : A99 - A100
  • [38] Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes
    Baskal, Svetlana
    Tsikas, Stefanos A.
    Begou, Olga
    Bollenbach, Alexander
    Lenzen, Sigurd
    Joerns, Anne
    Tsikas, Dimitrios
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [39] Reduced short-chain fatty acids and impaired glucose homeostasis in an animal model of accelerated type 1 diabetes
    Wessel, C.
    Blaut, M.
    Roden, M.
    Burkart, V.
    DIABETOLOGIA, 2019, 62 : S202 - S202
  • [40] Pathology of the pancreas and other organs in the diabetic LEW.1AR1/Ztm-iddm rat, a new model of spontaneous insulin-dependent diabetes mellitus
    Jörns, A
    Kubat, B
    Tiedge, M
    Wedekind, D
    Hedrich, HJ
    Klöppel, G
    Lenzen, S
    VIRCHOWS ARCHIV, 2004, 444 (02) : 183 - 189
12345